Gladstone’s Scientific Advisory Board is composed of renowned scientists from across the United States. Each year, they meet to review Gladstone’s scientific programs and advise our president and scientific directors.
As part of Gladstone’s strategic plan and due to the collaborative nature of our science, the advisory board was restructured to have a single organization-wide delegation, rather than separate groups of advisors for each individual institute. 2022 was the first year that the new board gathered together in San Francisco to hear the latest scientific updates from our researchers.
The board was overwhelmingly enthusiastic about the science they reviewed, as well as the culture and trajectory of Gladstone. We’re grateful for the significant investment of time they made in Gladstone, as well their advice and advocacy.
Celebrating 25 years of neurological disease research at Gladstone
History Institutional News News Release Neurological DiseaseThis distinction recognizes his and the institute’s pioneering blend of genomics and immunology toward the design and improvement of cancer immunotherapy
Institutional News Genomic Immunology Marson LabAndrew C. Yang joins Gladstone Institutes to decode the cross talk between the brain and body in aging and neurodegeneration
Institutional News News Release Alzheimer’s Disease Neurological Disease Yang Lab